Erythrocyte Microparticles Emerge as Cancer Vaccine Adjuvants

Company Tang laboratory (academic, China) Event Type Peer-reviewed publication Modality Autologous erythrocyte-derived microparticle adjuvant Asset UV-generated erythrocyte microparticles Target Dendritic-cell haem–REV-ERBα–PPARγ axis Disease Area Solid tumors (preclinical) Summary A peer reviewed Nature Biomedical Engineering study published online 23 October 2026 identifies ultraviolet-generated autologous erythrocyte microparticles…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *